These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 39097576)

  • 1. Breast cancer clinical trial participation among diverse patients at a comprehensive cancer center.
    Podany EL; Bulsara S; Sanchez K; Otte K; Ellis MJ; Kinik M
    NPJ Breast Cancer; 2024 Aug; 10(1):70. PubMed ID: 39097576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective comparison of cancer clinical trial availability and enrollment among adolescents/young adults treated at an adult cancer hospital or affiliated children's hospital.
    Thomas SM; Malvar J; Tran HH; Shows JT; Freyer DR
    Cancer; 2018 Oct; 124(20):4064-4071. PubMed ID: 30291804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accrual and retention of diverse patients in psychosocial cancer clinical trials.
    Hanvey GA; Padron A; Kacel EL; Cartagena G; Bacharz KC; McCrae CS; Robinson ME; Waxenberg LB; Antoni MH; Berry RB; Schultz GS; Castagno J; Pereira DB
    J Clin Transl Sci; 2022; 6(1):e45. PubMed ID: 35651964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating a community-partnered cancer clinical trials pilot intervention with African American communities.
    Green MA; Michaels M; Blakeney N; Odulana AA; Isler MR; Richmond A; Long DG; Robinson WS; Taylor YJ; Corbie-Smith G
    J Cancer Educ; 2015 Mar; 30(1):158-66. PubMed ID: 25564207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of socioeconomic status and race on trial participation for older women with breast cancer.
    Gross CP; Filardo G; Mayne ST; Krumholz HM
    Cancer; 2005 Feb; 103(3):483-91. PubMed ID: 15597407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of socioeconomic status on enrollment in clinical trials for cancer: A systematic review.
    Donzo MW; Nguyen G; Nemeth JK; Owoc MS; Mady LJ; Chen AY; Schmitt NC
    Cancer Med; 2024 Jan; 13(1):e6905. PubMed ID: 38169154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective, observational cohort study comparing cancer clinical trial availability and enrollment between early adolescents/young adults and children.
    Thomas SM; Malvar J; Tran H; Shows J; Freyer DR
    Cancer; 2018 Mar; 124(5):983-990. PubMed ID: 29149450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sociodemographic diversity in cancer clinical trials: New findings on the effect of race and ethnicity.
    Meyer S; Woldu HG; Sheets LR
    Contemp Clin Trials Commun; 2021 Mar; 21():100718. PubMed ID: 33604484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with breast cancer clinical trials participation and enrollment at a large academic medical center.
    Simon MS; Du W; Flaherty L; Philip PA; Lorusso P; Miree C; Smith D; Brown DR
    J Clin Oncol; 2004 Jun; 22(11):2046-52. PubMed ID: 15082724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examining Differences in Opportunity and Eligibility for Cancer Clinical Trial Participation Based on Sociodemographic and Disease Characteristics.
    Rearden J; Hanlon AL; Ulrich C; Brooks-Carthon M; Sommers M
    Oncol Nurs Forum; 2016 Jan; 43(1):57-66. PubMed ID: 26679445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review of barriers and facilitators to clinical trial enrollment among adolescents and young adults with cancer: Identifying opportunities for intervention.
    Siembida EJ; Loomans-Kropp HA; Trivedi N; O'Mara A; Sung L; Tami-Maury I; Freyer DR; Roth M
    Cancer; 2020 Mar; 126(5):949-957. PubMed ID: 31869454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Creation of a quality improvement collaborative to address adolescent and young adult cancer clinical trial enrollment: ATAQI (AYA trial access quality initiative).
    Hesko C; Mittal N; Avutu V; Thomas SM; Heath JL; Roth ME
    Curr Probl Cancer; 2023 Dec; 47(6):100898. PubMed ID: 36207194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating potential disparities in clinical trial eligibility and enrollment at an NCI-designated comprehensive cancer center.
    Patel MA; Shah JL; Brinley FJ; Abrahamse PH; Veenstra CM; Schott AF
    Cancer Med; 2023 Jun; 12(11):12802-12812. PubMed ID: 37151163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urate oxidase for the prevention and treatment of tumour lysis syndrome in children with cancer.
    Cheuk DK; Chiang AK; Chan GC; Ha SY
    Cochrane Database Syst Rev; 2014 Aug; (8):CD006945. PubMed ID: 25121561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barriers to therapeutic clinical trials enrollment: differences between African-American and white cancer patients identified at the time of eligibility assessment.
    Penberthy L; Brown R; Wilson-Genderson M; Dahman B; Ginder G; Siminoff LA
    Clin Trials; 2012 Dec; 9(6):788-97. PubMed ID: 23033547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disparities in phase 1 cancer clinical trial enrollment.
    Perni S; Moy B; Nipp RD
    Cancer; 2021 Dec; 127(23):4464-4469. PubMed ID: 34379799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urate oxidase for the prevention and treatment of tumour lysis syndrome in children with cancer.
    Cheuk DK; Chiang AK; Chan GC; Ha SY
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD006945. PubMed ID: 28272834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of race and ethnicity in the State Children's Health Insurance Program (SCHIP) in four states: are there baseline disparities, and what do they mean for SCHIP?
    Shone LP; Dick AW; Brach C; Kimminau KS; LaClair BJ; Shenkman EA; Col JF; Schaffer VA; Mulvihill F; Szilagyi PG; Klein JD; VanLandeghem K; Bronstein J
    Pediatrics; 2003 Dec; 112(6 Pt 2):e521. PubMed ID: 14654674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barriers and Facilitators to Adolescent and Young Adult Cancer Trial Enrollment: NCORP Site Perspectives.
    Siembida EJ; Loomans-Kropp HA; Tami-Maury I; Freyer DR; Sung L; Crosswell HE; Pollock BH; Roth ME
    JNCI Cancer Spectr; 2021 Jun; 5(3):. PubMed ID: 34104866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.